文献速递乳腺癌支持与姑息治疗

芳香化酶抑制剂治疗乳腺癌幸存者疲劳患病率及危险因素

Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors.
PubMed 文献 · Eur J Cancer · 2018-07-14

该横断面调查纳入某大型大学医院乳腺肿瘤门诊1103例接受辅助芳香化酶抑制剂(AI)治疗的0–III期绝经后乳腺癌患者,以简明疲劳量表最疲乏条目≥4分定义为中重度疲劳。结果显示616例(55.8%)存在中重度疲劳,年轻、受教育程度高、BMI升高、疼痛严重及失眠与疲劳相关。

要点

  • 接受AI治疗的乳腺癌患者中中重度疲劳比例达55.8%。
  • 55岁以下、大学及以上学历、超重或肥胖者疲劳风险更高。
  • 疲劳与疼痛严重程度(r=0.48)及失眠(r=0.62)显著相关。

核心结论

  • 接受芳香化酶抑制剂治疗的乳腺癌幸存者中,中重度疲劳主诉超过50%,且与年轻年龄、较高受教育程度、较高BMI、疼痛严重程度和失眠高度相关。

研究设计与样本

  • 横断面调查研究,在大型大学医院乳腺肿瘤门诊开展。
  • 对象为接受辅助AI治疗的0–III期绝经后乳腺癌女性。
  • 以简明疲劳量表最疲乏条目≥4分定义为中重度疲劳,采用多因素logistic回归评估危险因素。
  • 共纳入1103例参与者。

主要发现

  • 1103例参与者中616例(55.8%)存在中重度疲劳。
  • 55岁以下女性较65岁以上女性更易报告中重度疲劳(AOR=1.58,95%CI=1.07–2.35;p=0.023)。
  • 大学及以上学历者较高中学历及以下者更易报告中重度疲劳(AOR=1.40,95%CI=1.02–1.91;p=0.037)。
  • 超重者中重度疲劳风险升高(AOR=1.37,95%CI=1.01–1.84,p=0.042),肥胖者更高(AOR=2.08,95%CI=1.53–2.81,p<0.001)。
  • 疲劳与疼痛严重程度(r=0.48,p<0.001)及失眠(r=0.62,p<0.001)显著相关。

关键数值与推荐

  • 中重度疲劳判定标准:简明疲劳量表最疲乏条目评分≥4分。
  • 中重度疲劳患病率:616/1103(55.8%)。

临床怎么用

  • 对接受AI治疗的乳腺癌患者应常规筛查疲劳,尤其关注55岁以下、受教育程度较高及超重或肥胖者。
  • 管理疲劳时可同时评估并干预疼痛与失眠。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Fatigue is the most common and distressing symptom experienced by cancer survivors. This study sought to determine the prevalence and risk factors for fatigue among breast cancer (BC) survivors receiving aromatase inhibitors (AIs). MATERIAL AND METHODS: We conducted a cross-sectional survey study among postmenopausal women with stage 0 to III BC receiving adjuvant AI therapy at the outpatient breast oncology clinic of a large university hospital. Participants with a score ≥4 on the 'worst fatigue' item of the Brief Fatigue Inventory were classified as having moderate or severe fatigue. Multivariate logistic regression analyses were performed to evaluate risk factors. RESULTS: Among 1103 participants, 616 (55.8%) had moderate or severe fatigue. In the multivariate logistic regression model, women younger than 55 years were significantly more likely to report moderate to severe fatigue than women older than 65 years (adjusted odds ratio [AOR] = 1.58, 95% confidence interval [CI] = 1.07-2.35; p = 0.023). Compared to women with high school or less education, women with college or more education were significantly more likely to report moderate to severe fatigue (AOR = 1.40, 95% CI = 1.02-1.91; p = 0.037). Increasing body mass index (BMI) was significantly associated with increased risk of experiencing moderate to severe fatigue (overweight: AOR = 1.37, 95% CI = 1.01-1.84, p = 0.042; obesity: AOR = 2.08, 95% CI = 1.53-2.81, p < 0.001). Fatigue was significantly correlated with pain severity (r = 0.48, p < 0.001) and insomnia (r = 0.62, p < 0.001). CONCLUSION: Moderate to severe fatigue complaints exceed 50% among AI users. Fatigue is highly related to younger age, higher education level, higher BMI, pain severity and insomnia.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Mao H, Bao T, Shen X, et al. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors. Eur J Cancer. 2018. PMID: 30014974. doi:10.1016/j.ejca.2018.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。